Results 91 to 100 of about 29,013 (278)

Acute Onset of Dark Urine in a Patient with LVAD Pump Dysfunction [PDF]

, 2021
James Alstott, Roy Jhagroo
openalex   +1 more source

Single‐Incision Anterolateral Thoracotomy for LVAD Implantation: A Novel Minimally Invasive Approach

Artificial Organs, EarlyView.
A novel single‐incision anterolateral thoracotomy technique enables complete HeartMate 3 implantation without sternotomy, minimizing surgical trauma and accelerating recovery. This minimally invasive approach is feasible, safe, and may represent a new standard in advanced heart failure surgery.
Ali Saad Merzah, Günes Dogan, Alina Zubarevich, Stefan Rümke, Bastian Schmack, Ezin Deniz, Jasmin Hanke, Arjang Ruhparwar, Jan D. Schmitto, Alexander Weymann   +9 more
wiley   +1 more source

Impact of centrifugal-flow left ventricular assist device implantation on the disease course, functional class, and quality of life in patients with end-stage heart failure with reduced ejection fraction. A 6-month follow-up experience

Российский кардиологический журнал
Aim. To study mortality, postoperative complications, clinical course, and quality of life of patients with heart failure (HF) within 6 months after left ventricular assist device (LVAD) implantation.Material and methods.
Zh. A. Shakhramanova, O Yu. Narusov, V. A. Amanatova, Yu. F. Osmolovskaya, K. G. Ganaev, A. A. Shiryaev, R. S. Akchurin, I. A. Merkulova, D. V. Pevsner, M. A. Saidova, S. N. Tereschenko   +10 more
doaj   +1 more source

A Call for Guidance in the Use of Left Ventricular Assist Devices in Older Adults [PDF]

, 2012
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90290/1/jgs3740 ...
Afilalo, Almeida, Baba, Baker, Baumwol, Dudzinski, Eshelman, Gorodeski, Gure, Hernandez, Kirklin, Marcus, Petrucci, Rector, Rizzieri, Roger, Rogers, Shapiro, Slaughter, Slaughter, Slaughter, Spertus, Starling, Sudore, Swetz, Swetz   +25 more
core   +1 more source

The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs, Olivia Frost, Arian Arjomandi Rad, Wing Kiu Chou, Sadeq Al‐Saegh, Alina Zubarevich, Alexander Weymann, Arjang Ruhparwar, Lukman Amanov, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +11 more
wiley   +1 more source

Stopping LVAD Bleeding [PDF]

Circulation Research, 2017
Left ventricular assist devices (LVADs) are efficient pumps that assist the circulation. They are rapidly evolving and being inserted into an increasing number of patients with advanced heart failure either as a bridge to transplantation or increasingly as destination therapy.
openaire   +2 more sources

Heart transplantation and left ventricular assist systems: not too early, not too late [PDF]

, 2017
Editorial ...
Anguita Sanchez, Aspromonte, Feldman, Francis, Gustafsson, Jessup, JJ, Lund, Lund, McDonagh, McDonagh, Mehra, Peura, Steffen, Westenbrink   +14 more
core   +2 more sources

Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen‐Year Longitudinal Profile

Artificial Organs, EarlyView.
Our study of 1026 LVAD implants revealed HeartWare had lower driveline infection rates than other LVAD types. In addition, severe diabetes was associated with higher risk, while older age and coronary artery disease were linked to a lower risk of driveline infections.
Anh Nguyen, Alexis Shafii, Gabriel Loor, Andrew Civitello, O. Howard Frazier, Todd Rosengart, Kenneth Liao   +6 more
wiley   +1 more source

Computational analysis of the hemodynamic characteristics under interaction influence of β-blocker and LVAD

BioMedical Engineering OnLine, 2018
Background Hemodynamic characteristics of the interaction influence among support level and model of LVAD, and coupling β-blocker has not been reported.
Kaiyun Gu, Zhe Zhang, Yu Chang, Bin Gao, Feng Wan   +4 more
doaj   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source